# NHS National Generic Pharmaceuticals Wave 13

> A sourced UK public sector contract award published by ATAMIS LTD.

## Key facts

- Buyer: [ATAMIS LTD](/buyers/atamis-ltd/contract-awards)
- Supplier: [Pfizer Ltd](/suppliers/pfizer/public-sector-contract-awards)
- Award value: £469,741,550
- Tender value: £469,741,550
- Award date: 30 November 2021
- Published: 3 August 2022
- Contract start: 1 February 2022
- Contract end: 31 May 2024
- Stage: awarded
- Procurement category: goods
- Notice ID: f872d76f-37e6-4b7e-b25e-c952ac8a42eb-560066
- OCID: ocds-b5fd17-7ded634b-6b01-4af7-afda-87458f7f80be

## Description

Invitation to offer for NHS National Generic Pharmaceuticals Wave 13 Offer reference number: CM/PHG/17/5532 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend \(at the Authority's sole discretion\) for a period or periods up to a total of 48 months\. Potential periods of call-offs under the framework agreement: Transition \(Everolimus\) CESW: 1 March 2022 - 30 September 2023 \(19 months\) LSNE: 1 March 2022 - 31 January 2023 \(11 months\) NWLN: 1 March 2022 - 31 January 2023 \(11 months\) Oral Products plus non-parenterals All Regions: 1 March 2022 - 31 May 2024 \(27 months\) Hospital Only Products CESW: 1 February 2022 - 30 September 2023 \(20 months\) LSNE: 1 February 2022 - 31 May 2024 \(28 months\) NWLN: 1 February 2022 - 31 January 2023 \(12 months\)

## Related contract awards

- [Avon & Bedford Court 76-92 Church Street Weybridge, Surrey, KT13 8DL](/contracts/ocds-b5fd17-dabfc9e7-cefc-4980-81a5-e3546200dd50) — ATAMIS LTD
- [UKRI-5133 MRC LMB Microscope Servicing](/contracts/ocds-b5fd17-f2c1e0a3-93e6-4530-a6ea-b4044e7f225c) — ATAMIS LTD
- [Data Reporting & Cloud Support](/contracts/ocds-b5fd17-47ee6157-4143-4c24-b458-1ce3b7b7f4ed) — ATAMIS LTD
- [Assurance of SW's Management Approach Policies](/contracts/ocds-b5fd17-4e1daabd-efc6-48cb-9214-3b41a0ba1b8e) — ATAMIS LTD
- [Pneumococcal vaccine for adults and at risk groups \(2025\)](/contracts/ocds-b5fd17-192951c1-2095-4648-9aee-ffa587e6fbcf) — UK Health Security Agency
- [NHS Framework - Blood Disorders including Haemophilia A and B - July 2024](/contracts/ocds-b5fd17-78480ca7-506a-4fbd-ab2d-b535c8904519) — NHS England
- [Bleeding Disorders including Haemophilia B](/contracts/ocds-b5fd17-3223ee06-289a-4576-a570-9458205ac102) — NHS England
- [NHS National Generic Pharmaceuticals Wave 13](/contracts/ocds-b5fd17-3856df43-01d6-4042-a1e6-a1524397d100) — ATAMIS LTD
- [Provision of Liquid Fuels](/contracts/ocds-b5fd17-f75da3a5-e92f-4894-a716-a058346b7007) — Epping Forest District Council
- [BDC Material Supply & Associated Services - Lot 1 - Plumbing, Heating Via PFH](/contracts/ocds-b5fd17-755554cb-c6f1-4f6b-a969-866d60e94a38) — Bromsgrove District Council
- [Supply of Digital PCR including Consumables and Maintenance](/contracts/ocds-b5fd17-7b8e343c-035c-4319-bf59-a805e84f5d87) — NHS Blood and Transplant
- [PAM 7036/27 - RFL - MEMG CAPITAL - 2 X Desktop Keypoint\.NET Focus Systems, Windows 10 LTSC](/contracts/ocds-b5fd17-ce95b1ba-dc21-4ef8-a157-60a41c4f827c) — Royal Free London NHS Foundation Trust

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/f872d76f-37e6-4b7e-b25e-c952ac8a42eb-560066)